Infantile Spasms Therapeutics Market by Therapeutic Class (Anticonvulsants, Corticosteroids, and Others), Drug Type (Vigabatrin, Adrenocorticotropic Hormone, and Others (Phase III)), Dosage (Solid, Liquid), Route of Administration (Oral, Parenteral, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), End User (Hospitals, Clinics, and Others), and Region 2025-2033

Infantile Spasms Therapeutics Market by Therapeutic Class (Anticonvulsants, Corticosteroids, and Others), Drug Type (Vigabatrin, Adrenocorticotropic Hormone, and Others (Phase III)), Dosage (Solid, Liquid), Route of Administration (Oral, Parenteral, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), End User (Hospitals, Clinics, and Others), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A6789

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Infantile Spasms Therapeutics Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Therapeutic Class
    6.1    Anticonvulsants
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Corticosteroids
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Others
        6.3.1 Market Trends
        6.3.2 Market Forecast
7    Market Breakup by Drug Type
    7.1    Vigabatrin
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Adrenocorticotropic Hormone
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Others (Phase III)
        7.3.1 Market Trends
        7.3.2 Market Forecast
8    Market Breakup by Dosage 
    8.1    Solid
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Liquid
        8.2.1 Market Trends
        8.2.2 Market Forecast
9    Market Breakup by Route of Administration
    9.1    Oral
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Parenteral
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Others
        9.3.1 Market Trends
        9.3.2 Market Forecast
10    Market Breakup by Distribution Channel
    10.1    Hospital Pharmacy
        10.1.1 Market Trends
        10.1.2 Market Forecast
    10.2    Retail Pharmacy
        10.2.1 Market Trends
        10.2.2 Market Forecast
    10.3    Online Pharmacy
        10.3.1 Market Trends
        10.3.2 Market Forecast
11    Market Breakup by End User
    11.1    Hospitals
        11.1.1 Market Trends
        11.1.2 Market Forecast
    11.2    Clinics
        11.2.1 Market Trends
        11.2.2 Market Forecast
    11.3    Others
        11.3.1 Market Trends
        11.3.2 Market Forecast
12    Market Breakup by Region
    12.1    North America
        12.1.1 United States
           12.1.1.1 Market Trends
           12.1.1.2 Market Forecast
        12.1.2 Canada
           12.1.2.1 Market Trends
           12.1.2.2 Market Forecast
    12.2    Asia-Pacific
        12.2.1 China
           12.2.1.1 Market Trends
           12.2.1.2 Market Forecast
        12.2.2 Japan
           12.2.2.1 Market Trends
           12.2.2.2 Market Forecast
        12.2.3 India
           12.2.3.1 Market Trends
           12.2.3.2 Market Forecast
        12.2.4 South Korea
           12.2.4.1 Market Trends
           12.2.4.2 Market Forecast
        12.2.5 Australia
           12.2.5.1 Market Trends
           12.2.5.2 Market Forecast
        12.2.6 Indonesia
           12.2.6.1 Market Trends
           12.2.6.2 Market Forecast
        12.2.7 Others
           12.2.7.1 Market Trends
           12.2.7.2 Market Forecast
    12.3    Europe
        12.3.1 Germany
           12.3.1.1 Market Trends
           12.3.1.2 Market Forecast
        12.3.2 France
           12.3.2.1 Market Trends
           12.3.2.2 Market Forecast
        12.3.3 United Kingdom
           12.3.3.1 Market Trends
           12.3.3.2 Market Forecast
        12.3.4 Italy
           12.3.4.1 Market Trends
           12.3.4.2 Market Forecast
        12.3.5 Spain
           12.3.5.1 Market Trends
           12.3.5.2 Market Forecast
        12.3.6 Russia
           12.3.6.1 Market Trends
           12.3.6.2 Market Forecast
        12.3.7 Others
           12.3.7.1 Market Trends
           12.3.7.2 Market Forecast
    12.4    Latin America
        12.4.1 Brazil
           12.4.1.1 Market Trends
           12.4.1.2 Market Forecast
        12.4.2 Mexico
           12.4.2.1 Market Trends
           12.4.2.2 Market Forecast
        12.4.3 Others
           12.4.3.1 Market Trends
           12.4.3.2 Market Forecast
    12.5    Middle East and Africa
        12.5.1 Market Trends
        12.5.2 Market Breakup by Country
        12.5.3 Market Forecast
13    Drivers, Restraints, and Opportunities
    13.1    Overview
    13.2    Drivers
    13.3    Restraints
    13.4    Opportunities
14    Value Chain Analysis
15    Porters Five Forces Analysis

    15.1    Overview
    15.2    Bargaining Power of Buyers
    15.3    Bargaining Power of Suppliers
    15.4    Degree of Competition
    15.5    Threat of New Entrants
    15.6    Threat of Substitutes
16    Price Analysis
17    Competitive Landscape

    17.1    Market Structure
    17.2    Key Players
    17.3    Profiles of Key Players
        17.3.1    H. Lundbeck A/S
           17.3.1.1 Company Overview
           17.3.1.2 Product Portfolio
           17.3.1.3 Financials
           17.3.1.4 SWOT Analysis
        17.3.2    Mallinckrodt plc
           17.3.2.1 Company Overview
           17.3.2.2 Product Portfolio
           17.3.2.3 Financials
        17.3.3    ORPHELIA Pharma
           17.3.3.1 Company Overview
           17.3.3.2 Product Portfolio
        17.3.4    Teva Pharmaceuticals USA Inc. (Teva Pharmaceutical Industries Ltd.)
           17.3.4.1 Company Overview
           17.3.4.2 Product Portfolio

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

​Figure 1: Global: Infantile Spasms Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Infantile Spasms Therapeutics Market: Sales Value (in Million USD), 2019-2024
Figure 3: Global: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 4: Global: Infantile Spasms Therapeutics Market: Breakup by Therapeutic Class (in %), 2024
Figure 5: Global: Infantile Spasms Therapeutics Market: Breakup by Drug Type (in %), 2024
Figure 6: Global: Infantile Spasms Therapeutics Market: Breakup by Dosage (in %), 2024
Figure 7: Global: Infantile Spasms Therapeutics Market: Breakup by Route of Administration (in %), 2024
Figure 8: Global: Infantile Spasms Therapeutics Market: Breakup by Distribution Channel (in %), 2024
Figure 9: Global: Infantile Spasms Therapeutics Market: Breakup by End User (in %), 2024
Figure 10: Global: Infantile Spasms Therapeutics Market: Breakup by Region (in %), 2024
Figure 11: Global: Infantile Spasms Therapeutics (Anticonvulsants) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Infantile Spasms Therapeutics (Anticonvulsants) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Infantile Spasms Therapeutics (Corticosteroids) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Infantile Spasms Therapeutics (Corticosteroids) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Infantile Spasms Therapeutics (Other Therapeutic Classes) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Infantile Spasms Therapeutics (Other Therapeutic Classes) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Infantile Spasms Therapeutics (Vigabatrin) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Infantile Spasms Therapeutics (Vigabatrin) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Infantile Spasms Therapeutics (Adrenocorticotropic Hormone) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Infantile Spasms Therapeutics (Adrenocorticotropic Hormone) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Infantile Spasms Therapeutics (Other Drug Types) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Infantile Spasms Therapeutics (Other Drug Types) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: Infantile Spasms Therapeutics (Solid) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: Infantile Spasms Therapeutics (Solid) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: Global: Infantile Spasms Therapeutics (Liquid) Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: Global: Infantile Spasms Therapeutics (Liquid) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: Global: Infantile Spasms Therapeutics (Oral) Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: Global: Infantile Spasms Therapeutics (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: Global: Infantile Spasms Therapeutics (Parenteral) Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: Global: Infantile Spasms Therapeutics (Parenteral) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: Global: Infantile Spasms Therapeutics (Other Routes of Administration) Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: Global: Infantile Spasms Therapeutics (Other Routes of Administration) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: Global: Infantile Spasms Therapeutics (Hospital Pharmacy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: Global: Infantile Spasms Therapeutics (Hospital Pharmacy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: Global: Infantile Spasms Therapeutics (Retail Pharmacy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: Global: Infantile Spasms Therapeutics (Retail Pharmacy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: Global: Infantile Spasms Therapeutics (Online Pharmacy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: Global: Infantile Spasms Therapeutics (Online Pharmacy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: Global: Infantile Spasms Therapeutics (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: Global: Infantile Spasms Therapeutics (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: Global: Infantile Spasms Therapeutics (Clinics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: Global: Infantile Spasms Therapeutics (Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: Global: Infantile Spasms Therapeutics (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: Global: Infantile Spasms Therapeutics (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: North America: Infantile Spasms Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: North America: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: United States: Infantile Spasms Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: United States: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: Canada: Infantile Spasms Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: Canada: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: Asia-Pacific: Infantile Spasms Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: Asia-Pacific: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: China: Infantile Spasms Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: China: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: Japan: Infantile Spasms Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: Japan: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: India: Infantile Spasms Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: India: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: South Korea: Infantile Spasms Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: South Korea: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: Australia: Infantile Spasms Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: Australia: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: Indonesia: Infantile Spasms Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: Indonesia: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: Others: Infantile Spasms Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: Others: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: Europe: Infantile Spasms Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: Europe: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: Germany: Infantile Spasms Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 70: Germany: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: France: Infantile Spasms Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 72: France: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 73: United Kingdom: Infantile Spasms Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 74: United Kingdom: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 75: Italy: Infantile Spasms Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 76: Italy: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 77: Spain: Infantile Spasms Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 78: Spain: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 79: Russia: Infantile Spasms Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 80: Russia: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 81: Others: Infantile Spasms Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 82: Others: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 83: Latin America: Infantile Spasms Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 84: Latin America: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 85: Brazil: Infantile Spasms Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 86: Brazil: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 87: Mexico: Infantile Spasms Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 88: Mexico: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 89: Others: Infantile Spasms Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 90: Others: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 91: Middle East and Africa: Infantile Spasms Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 92: Middle East and Africa: Infantile Spasms Therapeutics Market: Breakup by Country (in %), 2024
Figure 93: Middle East and Africa: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 94: Global: Infantile Spasms Therapeutics Industry: Drivers, Restraints, and Opportunities
Figure 95: Global: Infantile Spasms Therapeutics Industry: Value Chain Analysis
Figure 96: Global: Infantile Spasms Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Infantile Spasms Therapeutics Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Infantile Spasms Therapeutics Market Forecast: Breakup by Therapeutic Class (in Million USD), 2025-2033
Table 3: Global: Infantile Spasms Therapeutics Market Forecast: Breakup by Drug Type (in Million USD), 2025-2033
Table 4: Global: Infantile Spasms Therapeutics Market Forecast: Breakup by Dosage (in Million USD), 2025-2033
Table 5: Global: Infantile Spasms Therapeutics Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
Table 6: Global: Infantile Spasms Therapeutics Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
Table 7: Global: Infantile Spasms Therapeutics Market Forecast: Breakup by End User (in Million USD), 2025-2033
Table 8: Global: Infantile Spasms Therapeutics Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 9: Global: Infantile Spasms Therapeutics Market: Competitive Structure
Table 10: Global: Infantile Spasms Therapeutics Market: Key Players

Infantile Spasms Therapeutics Market by Therapeutic Class (Anticonvulsants, Corticosteroids, and Others), Drug Type (Vigabatrin, Adrenocorticotropic Hormone, and Others (Phase III)), Dosage (Solid, Liquid), Route of Administration (Oral, Parenteral, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), End User (Hospitals, Clinics, and Others), and Region 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials